Hemab Therapeutics (COAG) vs Kardigan (KARD)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Hemab Therapeutics is the larger company by market cap ($1.56 billion vs $1.43 billion), about 1.1 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | COAG | KARD |
|---|---|---|
| Share price | $33.49 | $15.33 |
| Market cap | $1.56B | $1.43B |
| 1-day change | +8.42% | +7.96% |
| EPS (TTM) | $-4.33 | $-10.65 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $55.42 | $27.00 |
| 52-week low | $23.00 | $12.23 |
| Distance from 52-week high | -39.57% | -43.22% |
| Analyst consensus | none | strong_buy |
| Avg. price target upside | +82.74% | +175.60% |
| Average volume | 458.71K | 487.54K |
| Shares outstanding | 46.71M | 93.50M |
| Employees | 59 | 241 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Hemab Therapeutics
COAG stock →Hemab Therapeutics Holdings, Inc. operates as a clinical-stage biotechnology company developing therapies that reimagine the treatment of blood coagulation disorders to sustain life and human resilience in United States of America and Denmark.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 59 employees
About Kardigan
KARD stock →Kardigan, Inc. operates as a biopharmaceutical company focused on developing medicines for cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 241 employees
COAG vs KARD FAQ
Which is bigger, Hemab Therapeutics or Kardigan?
Hemab Therapeutics (COAG) is larger, with a market capitalization of $1.56B compared with $1.43B for Kardigan (KARD).
Are Hemab Therapeutics and Kardigan in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Biological Products (No Diagnostic Substances) for Hemab Therapeutics and Biotechnology: Pharmaceutical Preparations for Kardigan.